Evidence map›Paper›PMID 40747127›Full record

ArticleBladder (San Francisco, Calif.)2025

Predictive value of mitotic figure counts in tumor progression of non-invasive high-grade papillary urothelial carcinoma of the urinary bladder: A retrospective study from a single cancer center.

Yan Hu, Susan Karki, Weiwei Chen, Yunguang Liu, Norbert Sule, Bo Xu

Abstract read
In one paragraph

Article in Bladder (San Francisco, Calif.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yan HuDepartment of Pathology, State University of New York, Buffalo, New York 14263, United States of America.
Susan KarkiDepartment of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States of America.
Weiwei ChenDepartment of Pathology, State University of New York, Buffalo, New York 14263, United States of America.
Yunguang LiuDepartment of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States of America.
Norbert SuleDepartment of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States of America.
Bo XuDepartment of Pathology, State University of New York, Buffalo, New York 14263, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Urothelial carcinoma (UC) is the most common type of bladder malignancy. Although the majority of UC present as non-invasive tumors, a subset of them progress into invasive cancer and cause significant morbidity and mortality. Objective: In this study, we examined the association between tumor mitotic activity associated and the progression of non-invasive high-grade papillary UC of the bladder. Methods: Forty-four cases of tumors that met the selection criteria were retrieved from the Department of Pathology archives, and, for each case, mitotic figures were counted in 10 high-power fields (HPF) by two independent pathologists. Tumor progression was defined as the invasion of the tumor into the subepithelial connective tissue (lamina propria) or beyond during follow-ups. In addition, tumors that later exhibited distant metastases were included in the tumor progression group. Results: Our study revealed that the average mitotic count per 10 HPF in the tumor progression group was significantly higher ( Conclusion: The findings of our study provided valuable information for further stratification of risk factors among patients with non-invasive high-grade papillary UC of the bladder. Patients with high mitotic figure count in their initial biopsies should be monitored closely or treated earlier to prevent their tumors from progressing into invasive carcinoma.

Indexed as

BladderMitotic figure countNon-invasive urothelial carcinomaPredictive valueTumor progression

Identifiers

PMID40747127
PMCPMC12308121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.